Lineage Cell Therapeutics, Inc. Common Stock (LCTX) Operating Expenses & History | Stock Alarm

Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock · Operating Expenses

LCTX Operating Expenses

Latest reported$39.49Mperiod endingJun 30, 2026

LCTX Operating Expenses ($400.00K → $39.49M)

Annual operating expenses

High-resolution chart · PNG

LCTX operating expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lineage Cell Therapeutics, Inc. Common Stock Operating Expenses — Annual fiscal periods (USD)
Period ending	Operating Expenses (USD)
Dec 31, 2025	35,490,000
Dec 31, 2024	30,643,000
Dec 31, 2023	33,007,000
Dec 31, 2022	36,495,000
Dec 31, 2021	51,681,000
Dec 31, 2020	26,835,000
Dec 31, 2019	39,942,000
Dec 31, 2018	42,109,000
Dec 31, 2017	42,280,000
Dec 31, 2016	60,861,000
Dec 31, 2015	67,236,000
Dec 31, 2014	51,791,894
Dec 31, 2013	40,594,768
Dec 31, 2012	26,259,275
Dec 31, 2011	23,041,193
Dec 31, 2010	13,532,433
Dec 31, 2009	5,445,434
Dec 31, 2008	4,326,424
Dec 31, 2007	2,268,494
Dec 31, 2006	2,913,879
Dec 31, 2005	2,921,611
Dec 31, 2004	2,657,151
Dec 31, 2003	2,246,250
Dec 31, 2002	2,421,649
Dec 31, 2001	3,646,510
Dec 31, 2000	5,218,230
Dec 31, 1999	6,856,751
Dec 31, 1998	2,400,000
Jun 30, 1998	3,300,000
Jun 30, 1996	2,100,000
Jun 30, 1995	2,600,000
Jun 30, 1994	1,700,000
Jun 30, 1993	800,000
Jun 30, 1992	400,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.